Univ.-Prof. Dipl.-Ing. Dr. Manfred Ogris
Summer term 2026
321014 VO Anatomie und Physiologie - B8
321026 VU Pharmazeutisches Imaging - B13 - (6 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (7 Kurse)
323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
Winter term 2025
321002 VO Steop Biologie für PharmazeutInnen - B2
321026 VU Pharmazeutisches Imaging - B13 - (4 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (5 Kurse)
321126 VU Pharmazeutisches Imaging - B13 - Zusatzkurse - (2 Kurse)
323005 VO Preclinical Drug Development - MPS4
Summer term 2025
321014 VO Anatomie und Physiologie - B8
321026 VU Pharmazeutisches Imaging - B13 - (5 Kurse)
321031 PR Biochemische und vertiefende pharmazeutisch-chemische Arbeitstechniken - B17 - (6 Kurse)
321126 VU Pharmazeutisches Imaging - B13 - Zusatzkurse - (2 Kurse)
323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
Schwerdt A, Zintchenko A, Concia M, Roesen N, Fisher K, Lindner LH et al. Hyperthermia-Induced Targeting of Thermosensitive Gene Carriers to Tumors. Human Gene Therapy. 2008 Nov;19(11):1283-1292. doi: 10.1089/hum.2008.064
Fella C, Walker GF, Ogris M, Wagner E. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding. European Journal of Pharmaceutical Sciences. 2008 Aug 7;34(4-5):309-320. doi: 10.1016/j.ejps.2008.05.004
Knorr V, Russ V, Allmendinger L, Ogris M, Wagner E. Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. Bioconjugate Chemistry. 2008 Aug;19(8):1625-1634. doi: 10.1021/bc8001858
Tietze N, Pelisek J, Philipp A, Roedl W, Merdan T, Tarcha P et al. Induction of apoptosis in murine neuroblastoma by systemic delivery of transferrin-shielded siRNA polyplexes for downregulation of Ran. Oligonucleotides. 2008 Jun;18(2):161-174. doi: 10.1089/oli.2008.0112
Ogris M, Kotha AK, Tietze N, Wagner E, Palumbo FS, Giammona G et al. Novel biocompatible cationic copolymers based on polyaspartylhydrazide being potent as gene vector on tumor cells. Pharmaceutical Research. 2007 Dec;24(12):2213-2222. doi: 10.1007/s11095-007-9403-4
Fahrmeir J, Gunther M, Tietze N, Wagner E, Ogris M. Electrophoretic purification of tumor-targeted polyethylenimine-based polyplexes reduces toxic side effects in vivo. Journal of Controlled Release. 2007 Oct 8;122(3):236-245. doi: 10.1016/j.jconrel.2007.05.013
de Bruin K, Ruthardt N, Fella C, Ogris M, Wagner E, Braeuchle C. Effects of photochemical release on a single cell level. Human Gene Therapy. 2007 Oct;18(10):1059-1059.
Philipp A, Meyer M, Zintchenko A, Ogris M, Plank C, Wagner E. Programmed endosomolytic conjugates for pDNA and siRNA delivery. Human Gene Therapy. 2007 Oct;18(10):1047-1047.
Meyer M, Zintchenko A, Ogris M, Wagner E. A dimethytmateic acid - metittin-potytysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. Journal of Gene Medicine. 2007 Sept;9(9):797-805. doi: 10.1002/jgm.1075
de Bruin K, Ruthardt N, von Gersdorff K, Bausinger R, Wagner E, Ogris M et al. Cellular dynamics of EGF receptor-targeted synthetic viruses (vol 15, pg 1297, 2007). Molecular Therapy. 2007 Sept;15(9):1735-1735. doi: 10.1038/sj.mt.6300247
Shir A, Ogris M, Wagner E, Levitzki A. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice (vol 3, art no e6, 2006). PLOS Medicine. 2007 Aug;4(8):1419-1419. 266. doi: 10.1371/journal.pmed.0040266
de Bruin K, Ruthardt N, von Gersdorff K, Bausinger R, Wagner E, Ogris M et al. Cellular dynamics of EGF receptor-targeted synthetic viruses. Molecular Therapy. 2007 Jul;15(7):1297-1305. doi: 10.1038/sj.mt.6300176
Kloeckner J, Wagner E, Ogris M. Degradable gene carriers based on oligomerized polyamines. European Journal of Pharmaceutical Sciences. 2006 Dec;29(5):414-425. doi: 10.1016/j.ejps.2006.08.002
Kloeckner J, Boeckle S, Persson D, Roedl W, Ogris M, Berg K et al. DNA polyplexes based on degradable oligoethylenimine-derivatives: Combination with EGF receptor targeting and endosomal release functions. Journal of Controlled Release. 2006 Nov 28;116(2):115-122. doi: 10.1016/j.jconrel.2006.07.002
von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, Wagner E, Ogris M. The internalization route resulting in successful gene expression depends on polyethylenimine both cell line and polyplex type. Molecular Therapy. 2006 Nov;14(5):745-753. doi: 10.1016/j.ymthe.2006.07.006
Cavallaro G, Campisi M, Licciardi M, Ogris M, Giammona G. Reversibly stable thiopolyplexes for intracellular delivery of genes. Journal of Controlled Release. 2006 Oct 27;115(3):322-334. doi: 10.1016/j.jconrel.2006.07.027
Kloeckner J, Bruzzano S, Ogris M, Wagner E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: Effect of chemical structure of polymer on biological properties. Bioconjugate Chemistry. 2006 Sept 20;17(5):1339-1345. doi: 10.1021/bc060133v
Multimodal optical tomography to study pharmacokinetics and pharmacodynamics in cancer models
Ogris, M. (Speaker)
14 Jun 2024
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Polycation based mRNA delivery: bottlenecks and solutions
Ogris, M. (Speaker)
21 May 2024 → 23 May 2024
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Wie unser Immunsystem uns vor Tumoren schützt
Ogris, M. (Speaker)
5 Mar 2024
Activity: Talks and presentations › Talk or oral contribution › Science to Public
Water-soluble NHC stabilized Gold Nanoparticles
Reithofer, M. (Speaker), Chin, J. M. (Contributor), Young, A. J. (Speaker), Sami, H. (Contributor), Eisen, C. (Contributor), Rubio, G. (Contributor), Tepe, N. (Contributor), Hofmann, T. (Contributor), Ogris, M. (Contributor) & Keppler, B. (Contributor)
11 Aug 2019
Activity: Talks and presentations › Talk or oral contribution › Science to Science
Department of Pharmaceutical Sciences
Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2D450
T: +43-1-4277-55551